Challenges and opportunities in controlling mosquito-borne infections (Q56373585)

https://api.crossref.org/works/10.1038%2FS41586-018-0318-5

7 January 2021

Global malaria mortality between 1980 and 2010: a systematic analysis

1 reference

https://api.crossref.org/works/10.1038%2FS41586-018-0318-5

7 January 2021

Malaria: Global progress 2000 - 2015 and future challenges

1 reference

https://api.crossref.org/works/10.1038%2FS41586-018-0318-5

7 January 2021

Urbanization and the global malaria recession

1 reference

https://api.crossref.org/works/10.1038%2FS41586-018-0318-5

7 January 2021

Global, regional, and national age-sex specific mortality for 264 causes of death, 1980-2016: a systematic analysis for the Global Burden of Disease Study 2016.

1 reference

https://api.crossref.org/works/10.1038%2FS41586-018-0318-5

7 January 2021

The global burden of dengue: an analysis from the Global Burden of Disease Study 2013

1 reference

https://api.crossref.org/works/10.1038%2FS41586-018-0318-5

7 January 2021

Increasing airline travel may facilitate co-circulation of multiple dengue virus serotypes in Asia

1 reference

https://api.crossref.org/works/10.1038%2FS41586-018-0318-5

7 January 2021

Global spread of dengue virus types: mapping the 70 year history

1 reference

https://api.crossref.org/works/10.1038%2FS41586-018-0318-5

7 January 2021

The dengue vector Aedes aegypti: what comes next

1 reference

https://api.crossref.org/works/10.1038%2FS41586-018-0318-5

7 January 2021

Climate change influences on global distributions of dengue and chikungunya virus vectors

1 reference

https://api.crossref.org/works/10.1038%2FS41586-018-0318-5

7 January 2021

Case Management of Dengue: Lessons Learned

1 reference

https://api.crossref.org/works/10.1038%2FS41586-018-0318-5

7 January 2021

Zika, Chikungunya, and Other Emerging Vector-Borne Viral Diseases

1 reference

https://api.crossref.org/works/10.1038%2FS41586-018-0318-5

7 January 2021

Chikungunya in the Americas

1 reference

https://api.crossref.org/works/10.1038%2FS41586-018-0318-5

7 January 2021

Chikungunya, an epidemic arbovirosis

1 reference

https://api.crossref.org/works/10.1038%2FS41586-018-0318-5

7 January 2021

Assessing the global threat from Zika virus

1 reference

https://api.crossref.org/works/10.1038%2FS41586-018-0318-5

7 January 2021

Where has all the Zika gone?

1 reference

https://api.crossref.org/works/10.1038%2FS41586-018-0318-5

7 January 2021

EPIDEMIOLOGY. Countering the Zika epidemic in Latin America

1 reference

https://api.crossref.org/works/10.1038%2FS41586-018-0318-5

7 January 2021

High Zika Virus Seroprevalence in Salvador, Northeastern Brazil Limits the Potential for Further Outbreaks

1 reference

https://api.crossref.org/works/10.1038%2FS41586-018-0318-5

7 January 2021

Existing and potential infection risk zones of yellow fever worldwide: a modelling analysis.

1 reference

https://api.crossref.org/works/10.1038%2FS41586-018-0318-5

7 January 2021

Benefits and risks of the Sanofi-Pasteur dengue vaccine: Modeling optimal deployment

1 reference

https://api.crossref.org/works/10.1038%2FS41586-018-0318-5

7 January 2021

The Long-Term Safety, Public Health Impact, and Cost-Effectiveness of Routine Vaccination with a Recombinant, Live-Attenuated Dengue Vaccine (Dengvaxia): A Model Comparison Study

1 reference

https://api.crossref.org/works/10.1038%2FS41586-018-0318-5

7 January 2021

Seven-Year Efficacy of RTS,S/AS01 Malaria Vaccine among Young African Children

1 reference

https://api.crossref.org/works/10.1038%2FS41586-018-0318-5

7 January 2021

Public health impact and cost-effectiveness of the RTS,S/AS01 malaria vaccine: a systematic comparison of predictions from four mathematical models

1 reference

https://api.crossref.org/works/10.1038%2FS41586-018-0318-5

7 January 2021

Efficacy and safety of RTS,S/AS01 malaria vaccine with or without a booster dose in infants and children in Africa: final results of a phase 3, individually randomised, controlled trial

1 reference

https://api.crossref.org/works/10.1038%2FS41586-018-0318-5

7 January 2021

Averting a malaria disaster: will insecticide resistance derail malaria control?

1 reference

https://api.crossref.org/works/10.1038%2FS41586-018-0318-5

7 January 2021

A critical assessment of vector control for dengue prevention

1 reference

https://api.crossref.org/works/10.1038%2FS41586-018-0318-5

7 January 2021

Is Dengue Vector Control Deficient in Effectiveness or Evidence?: Systematic Review and Meta-analysis

1 reference

https://api.crossref.org/works/10.1038%2FS41586-018-0318-5

7 January 2021

What do community-based dengue control programmes achieve? A systematic review of published evaluations.

1 reference

https://api.crossref.org/works/10.1038%2FS41586-018-0318-5

7 January 2021

Evidence-based vector control? Improving the quality of vector control trials

1 reference

https://api.crossref.org/works/10.1038%2FS41586-018-0318-5

7 January 2021

Daily Rhythms in Disease-Vector Insects

1 reference

https://api.crossref.org/works/10.1038%2FS41586-018-0318-5

7 January 2021

Gradual acquisition of immunity to severe malaria with increasing exposure.

1 reference

https://api.crossref.org/works/10.1038%2FS41586-018-0318-5

7 January 2021

Antigenic diversity and the transmission dynamics of Plasmodium falciparum.

1 reference

https://api.crossref.org/works/10.1038%2FS41586-018-0318-5

7 January 2021

Immune status alters the probability of apparent illness due to dengue virus infection: Evidence from a pooled analysis across multiple cohort and cluster studies.

1 reference

https://api.crossref.org/works/10.1038%2FS41586-018-0318-5

7 January 2021

Secondary infection as a risk factor for dengue hemorrhagic fever/dengue shock syndrome: an historical perspective and role of antibody-dependent enhancement of infection

1 reference

https://api.crossref.org/works/10.1038%2FS41586-018-0318-5

7 January 2021

Antibody-dependent enhancement of severe dengue disease in humans.

1 reference

https://api.crossref.org/works/10.1038%2FS41586-018-0318-5

7 January 2021

Reconstruction of antibody dynamics and infection histories to evaluate dengue risk

1 reference

https://api.crossref.org/works/10.1038%2FS41586-018-0318-5

7 January 2021

Analysis of repeat hospital admissions for dengue to estimate the frequency of third or fourth dengue infections resulting in admissions and dengue hemorrhagic fever, and serotype sequences.

1 reference

https://api.crossref.org/works/10.1038%2FS41586-018-0318-5

7 January 2021

Age-specificity of clinical dengue during primary and secondary infections

1 reference

https://api.crossref.org/works/10.1038%2FS41586-018-0318-5

7 January 2021

Potential for reduction of burden and local elimination of malaria by reducing Plasmodium falciparum malaria transmission: a mathematical modelling study

1 reference

https://api.crossref.org/works/10.1038%2FS41586-018-0318-5

7 January 2021

Reducing Plasmodium falciparum malaria transmission in Africa: a model-based evaluation of intervention strategies

1 reference

https://api.crossref.org/works/10.1038%2FS41586-018-0318-5

7 January 2021

Estimating the most efficient allocation of interventions to achieve reductions in Plasmodium falciparum malaria burden and transmission in Africa: a modelling study

1 reference

https://api.crossref.org/works/10.1038%2FS41586-018-0318-5

7 January 2021

Using Wolbachia for Dengue Control: Insights from Modelling

1 reference

https://api.crossref.org/works/10.1038%2FS41586-018-0318-5

7 January 2021

The global distribution and burden of dengue

1 reference

https://api.crossref.org/works/10.1038%2FS41586-018-0318-5

7 January 2021

Dengue diversity across spatial and temporal scales: Local structure and the effect of host population size

1 reference

https://api.crossref.org/works/10.1038%2FS41586-018-0318-5

7 January 2021

Time-varying, serotype-specific force of infection of dengue virus

1 reference

https://api.crossref.org/works/10.1038%2FS41586-018-0318-5

7 January 2021

Evidence based community mobilization for dengue prevention in Nicaragua and Mexico (Camino Verde, the Green Way): cluster randomized controlled trial

1 reference

https://api.crossref.org/works/10.1038%2FS41586-018-0318-5

7 January 2021

Association between Zika virus and microcephaly in French Polynesia, 2013–15: a retrospective study

1 reference

https://api.crossref.org/works/10.1038%2FS41586-018-0318-5

7 January 2021

Zika and the Risk of Microcephaly

1 reference

https://api.crossref.org/works/10.1038%2FS41586-018-0318-5

7 January 2021

Quantifying the Epidemiological Impact of Vector Control on Dengue

1 reference

https://api.crossref.org/works/10.1038%2FS41586-018-0318-5

7 January 2021

Dengue prevention and 35 years of vector control in Singapore

1 reference

https://api.crossref.org/works/10.1038%2FS41586-018-0318-5

7 January 2021

Nets, spray or both? The effectiveness of insecticide-treated nets and indoor residual spraying in reducing malaria morbidity and child mortality in sub-Saharan Africa

1 reference

https://api.crossref.org/works/10.1038%2FS41586-018-0318-5

7 January 2021

Indoor residual spraying in combination with insecticide-treated nets compared to insecticide-treated nets alone for protection against malaria: a cluster randomised trial in Tanzania

1 reference

https://api.crossref.org/works/10.1038%2FS41586-018-0318-5

7 January 2021

History of domestication and spread of Aedes aegypti--a review

1 reference

https://api.crossref.org/works/10.1038%2FS41586-018-0318-5

7 January 2021

Factors contributing to urban malaria transmission in sub-saharan Africa: a systematic review

1 reference

https://api.crossref.org/works/10.1038%2FS41586-018-0318-5

7 January 2021

Considerations in the design of clinical trials to test novel entomological approaches to dengue control

1 reference

https://api.crossref.org/works/10.1038%2FS41586-018-0318-5

7 January 2021

The global distribution of clinical episodes of Plasmodium falciparum malaria

1 reference

https://api.crossref.org/works/10.1038%2FS41586-018-0318-5

7 January 2021

Immunogenicity of the RTS,S/AS01 malaria vaccine and implications for duration of vaccine efficacy: secondary analysis of data from a phase 3 randomised controlled trial

1 reference

https://api.crossref.org/works/10.1038%2FS41586-018-0318-5

7 January 2021

Challenges of Vaccine Development for Zika Virus

1 reference

https://api.crossref.org/works/10.1038%2FS41586-018-0318-5

7 January 2021

Short-term Impact of Mass Drug Administration With Dihydroartemisinin Plus Piperaquine on Malaria in Southern Province Zambia: A Cluster-Randomized Controlled Trial

1 reference

https://api.crossref.org/works/10.1038%2FS41586-018-0318-5

7 January 2021

Role of mass drug administration in elimination of Plasmodium falciparum malaria: a consensus modelling study

1 reference

https://api.crossref.org/works/10.1038%2FS41586-018-0318-5

7 January 2021

Protective efficacy and safety of three antimalarial regimens for the prevention of malaria in young Ugandan children: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1038%2FS41586-018-0318-5

7 January 2021

Clinical efficacy and safety of a novel tetravalent dengue vaccine in healthy children in Asia: a phase 3, randomised, observer-masked, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1038%2FS41586-018-0318-5

7 January 2021

Efficacy of a tetravalent dengue vaccine in children in Latin America.

1 reference

https://api.crossref.org/works/10.1038%2FS41586-018-0318-5

7 January 2021

Modelling the cost-effectiveness of introducing the RTS,S malaria vaccine relative to scaling up other malaria interventions in sub-Saharan Africa.

1 reference

https://api.crossref.org/works/10.1038%2FS41586-018-0318-5

7 January 2021

Which Dengue Vaccine Approach Is the Most Promising, and Should We Be Concerned about Enhanced Disease after Vaccination? The Challenges of a Dengue Vaccine

1 reference

https://api.crossref.org/works/10.1038%2FS41586-018-0318-5

7 January 2021

Structural basis of potent Zika–dengue virus antibody cross-neutralization

1 reference

https://api.crossref.org/works/10.1038%2FS41586-018-0318-5

7 January 2021

Attractive Toxic Sugar Bait (ATSB) For Control of Mosquitoes and Its Impact on Non-Target Organisms: A Review

1 reference

https://api.crossref.org/works/10.1038%2FS41586-018-0318-5

7 January 2021

Indoor use of attractive toxic sugar bait (ATSB) to effectively control malaria vectors in Mali, West Africa

1 reference

https://api.crossref.org/works/10.1038%2FS41586-018-0318-5

7 January 2021

The potential impact of adding ivermectin to a mass treatment intervention to reduce malaria transmission: a modelling study

1 reference

https://api.crossref.org/works/10.1038%2FS41586-018-0318-5

7 January 2021

Wolbachia: master manipulators of invertebrate biology

1 reference

https://api.crossref.org/works/10.1038%2FS41586-018-0318-5

7 January 2021

A Wolbachia symbiont in Aedes aegypti limits infection with dengue, Chikungunya, and Plasmodium

1 reference

https://api.crossref.org/works/10.1038%2FS41586-018-0318-5

7 January 2021

The wMel Wolbachia strain blocks dengue and invades caged Aedes aegypti populations

1 reference

https://api.crossref.org/works/10.1038%2FS41586-018-0318-5

7 January 2021

Modeling the impact on virus transmission of Wolbachia-mediated blocking of dengue virus infection of Aedes aegypti

1 reference

https://api.crossref.org/works/10.1038%2FS41586-018-0318-5

7 January 2021

Wolbachia invades Anopheles stephensi populations and induces refractoriness to Plasmodium infection

1 reference

https://api.crossref.org/works/10.1038%2FS41586-018-0318-5

7 January 2021

Engineering the control of mosquito-borne infectious diseases

1 reference

https://api.crossref.org/works/10.1038%2FS41586-018-0318-5

7 January 2021

Control of Mosquito-Borne Infectious Diseases: Sex and Gene Drive

1 reference

https://api.crossref.org/works/10.1038%2FS41586-018-0318-5

7 January 2021

Malaria Control with Transgenic Mosquitoes

1 reference

https://api.crossref.org/works/10.1038%2FS41586-018-0318-5

7 January 2021

A synthetic sex ratio distortion system for the control of the human malaria mosquito

1 reference

https://api.crossref.org/works/10.1038%2FS41586-018-0318-5

7 January 2021

Site-specific selfish genes as tools for the control and genetic engineering of natural populations.

1 reference

https://api.crossref.org/works/10.1038%2FS41586-018-0318-5

7 January 2021

Requirements for effective malaria control with homing endonuclease genes

1 reference

https://api.crossref.org/works/10.1038%2FS41586-018-0318-5

7 January 2021

Germline Cas9 expression yields highly efficient genome engineering in a major worldwide disease vector, Aedes aegypti.

1 reference

https://api.crossref.org/works/10.1038%2FS41586-018-0318-5

7 January 2021

Highly efficient Cas9-mediated gene drive for population modification of the malaria vector mosquito Anopheles stephensi

1 reference

https://api.crossref.org/works/10.1038%2FS41586-018-0318-5

7 January 2021

Genetic approaches to interfere with malaria transmission by vector mosquitoes

1 reference

https://api.crossref.org/works/10.1038%2FS41586-018-0318-5

7 January 2021

Genome Investigations of Vector Competence in Aedes aegypti to Inform Novel Arbovirus Disease Control Approaches

1 reference

https://api.crossref.org/works/10.1038%2FS41586-018-0318-5

7 January 2021

Quantifying the impact of human mobility on malaria

1 reference

https://api.crossref.org/works/10.1038%2FS41586-018-0318-5

7 January 2021